[go: up one dir, main page]

GR3004281T3 - - Google Patents

Info

Publication number
GR3004281T3
GR3004281T3 GR910402220T GR910402220T GR3004281T3 GR 3004281 T3 GR3004281 T3 GR 3004281T3 GR 910402220 T GR910402220 T GR 910402220T GR 910402220 T GR910402220 T GR 910402220T GR 3004281 T3 GR3004281 T3 GR 3004281T3
Authority
GR
Greece
Prior art keywords
soporifics
pgds
tranquilizer
keto
dihydro
Prior art date
Application number
GR910402220T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004281T3 publication Critical patent/GR3004281T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
GR910402220T 1987-01-28 1992-04-07 GR3004281T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28

Publications (1)

Publication Number Publication Date
GR3004281T3 true GR3004281T3 (el) 1993-03-31

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910402220T GR3004281T3 (el) 1987-01-28 1992-04-07

Country Status (8)

Country Link
US (3) US5073569A (el)
EP (1) EP0281239B1 (el)
KR (1) KR930006201B1 (el)
AT (1) ATE74126T1 (el)
CA (1) CA1322749C (el)
DE (1) DE3869444D1 (el)
ES (1) ES2032956T3 (el)
GR (1) GR3004281T3 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化
ATE420857T1 (de) 1988-09-06 2009-01-15 Pfizer Health Ab Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
EP0410652B1 (en) * 1989-07-27 1995-05-17 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of 15-keto-prostanoic acid derivatives in the manufacture of a medicament for improvement of excretion of potassium ion
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE141794T1 (de) * 1991-03-14 1996-09-15 R Tech Ueno Ltd Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
ES2257860T3 (es) 1998-05-25 2006-08-01 Taisho Pharmaceutical Co., Ltd Agente inductor del sueño a base de derivados de prostaglandina.
ATE428429T1 (de) 2000-03-24 2009-05-15 Sucampo Ag Prostaglandine zur behandlung von lichtstrahlung erzeugten augenerkrankungen wie photoretinitis
DE60139002D1 (de) * 2000-04-06 2009-07-30 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
US8114911B2 (en) * 2002-10-23 2012-02-14 Sucampo Ag Prostaglandin compounds for the treatment of obesity
ES2591252T3 (es) 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional
WO2005002588A1 (en) * 2003-07-03 2005-01-13 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
KR101118935B1 (ko) 2003-08-21 2012-03-13 가부시키가이샤 아루떼꾸 우에노 안과용 조성물
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
US8202909B2 (en) 2005-01-27 2012-06-19 Sucampo Ag Method for treating central nervous system disorders
CN103919783A (zh) 2005-03-04 2014-07-16 苏坎波公司 治疗外周血管病的方法和组合物
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
CN101198334B (zh) * 2005-04-12 2013-02-06 苏坎波公司 前列腺素化合物和质子泵抑制剂用于治疗肠胃病的联合应用
JP4783794B2 (ja) 2006-01-24 2011-09-28 株式会社アールテック・ウエノ 軟ゼラチンカプセル製剤
NZ570190A (en) 2006-01-24 2011-03-31 Sucampo Ag Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
BRPI0708891A2 (pt) 2006-03-13 2011-06-28 R Tech Ueno Ltd composição aquosa
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
CA2830626A1 (en) 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia
SG10201606442QA (en) * 2011-08-05 2016-09-29 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
AR105029A1 (es) 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.

Also Published As

Publication number Publication date
ES2032956T3 (es) 1993-03-01
US5137915A (en) 1992-08-11
KR880008986A (ko) 1988-09-13
EP0281239A2 (en) 1988-09-07
EP0281239A3 (en) 1988-09-21
US5534547A (en) 1996-07-09
DE3869444D1 (de) 1992-04-30
ATE74126T1 (de) 1992-04-15
CA1322749C (en) 1993-10-05
US5073569A (en) 1991-12-17
EP0281239B1 (en) 1992-03-25
KR930006201B1 (ko) 1993-07-08

Similar Documents

Publication Publication Date Title
GR3004281T3 (el)
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
DE3869007D1 (de) Oxydation von alkanen.
IT8667677A1 (it) Procedimento e apparecchiatura per la formazione di masse refrattarie.
FI880866A7 (fi) 3-amino-dihydro-(1)-bensopyraner och -bensotiopyraner.
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
GR3004959T3 (el)
DE3875600D1 (de) Antiarrythmische derivate 2.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
FI881413A0 (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
AP8800109A0 (en) "Heterocyclic insecticides".
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
IL85425A0 (en) Anticonvulsant agents
JPS6440519A (en) Polyesters of 4,4-dihydroxydicyclohexyl
FI880680L (fi) Deemulgering av oljor.
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
FI860247A0 (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
GR3004866T3 (el)
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
IT8723266A0 (it) Procedimento per la fabbricazione di tappeti e simili.
Laux The semblance of Cymbeline
LT2342B (lt) 2,6-dioksopiperazino gavimo budas